Bullfrog AI (NASDAQ:BFRG – Get Free Report) and MDxHealth (NASDAQ:MDXH – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, profitability and analyst recommendations.
Profitability
This table compares Bullfrog AI and MDxHealth’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Bullfrog AI | N/A | -163.23% | -139.94% |
MDxHealth | -41.02% | -492.11% | -23.00% |
Insider & Institutional Ownership
1.0% of Bullfrog AI shares are held by institutional investors. 33.9% of Bullfrog AI shares are held by insiders. Comparatively, 1.7% of MDxHealth shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Earnings & Valuation
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Bullfrog AI | N/A | N/A | -$6.99 million | ($0.81) | -1.88 |
MDxHealth | $90.05 million | 1.31 | -$38.07 million | ($1.15) | -2.17 |
Bullfrog AI has higher earnings, but lower revenue than MDxHealth. MDxHealth is trading at a lower price-to-earnings ratio than Bullfrog AI, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Bullfrog AI and MDxHealth, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Bullfrog AI | 0 | 0 | 0 | 0 | 0.00 |
MDxHealth | 0 | 0 | 3 | 0 | 3.00 |
MDxHealth has a consensus target price of $7.00, indicating a potential upside of 181.12%. Given MDxHealth’s stronger consensus rating and higher probable upside, analysts plainly believe MDxHealth is more favorable than Bullfrog AI.
Risk & Volatility
Bullfrog AI has a beta of 0.48, indicating that its stock price is 52% less volatile than the S&P 500. Comparatively, MDxHealth has a beta of 1.31, indicating that its stock price is 31% more volatile than the S&P 500.
Summary
Bullfrog AI beats MDxHealth on 7 of the 13 factors compared between the two stocks.
About Bullfrog AI
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.
About MDxHealth
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. The company offers genomic prostate score which provides personalized genomic insights to both physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. It sells its products through urology sales force, consisting of direct sales representatives, strategic account managers, and regional sales managers. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.